Back to User profile » Mr Guillaume Germain
Papers published by Mr Guillaume Germain:
Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R
Journal of Asthma and Allergy 2023, 16:1309-1322
Published Date: 1 December 2023
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
Bogart M, Germain G, Laliberté F, Lejeune D, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1575-1586
Published Date: 24 July 2023
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation
Mannino D, Bogart M, Germain G, Huang SP, Ismaila AS, Laliberté F, Jung Y, MacKnight SD, Stiegler MA, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:491-504
Published Date: 5 March 2022
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1149-1161
Published Date: 22 April 2021
Characterizing Real-World Use Of Tiotropium In Asthma In The USA
Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S
Journal of Asthma and Allergy 2019, 12:309-321
Published Date: 7 October 2019
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:343-352
Published Date: 19 February 2019
Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
Llanos JP, Ortega H, Germain G, Duh MS, Lafeuille MH, Tiggelaar S, Bell CF, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2859-2868
Published Date: 12 September 2018
Burden of disease associated with a COPD eosinophilic phenotype
Ortega H, Llanos JP, Lafeuille MH, Germain G, Duh MS, Bell CF, Sama SR, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2425-2433
Published Date: 13 August 2018